Results 161 to 170 of about 1,297,479 (340)
Interleukin 2 activates a receptor-associated protein kinase. [PDF]
Stephen H. Benedict+2 more
openalex +1 more source
Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis
An injectable hydrogel is developed by chemically tethering IL‐4, an immunosuppressive cytokine, to a hyaluronic acid‐based backbone. The hydrogel reduces joint friction and exerts immunomodulatory effects. In a rheumatoid arthritis (RA) mouse model, it reduced inflammation, preserved cartilage, and promoted anti‐inflammatory immune responses.
Woojin Back+3 more
wiley +1 more source
Purification to apparent homogeneity of murine interleukin 1. [PDF]
S B Mizel, Diane Mizel
openalex +1 more source
A mitochondria‐targeted cationic nanoscale metal organic framework shows strong radiotherapy‐radiodynamic therapy effects and selectively releases digitonin in acidic tumor microenvironments to induce disulfidptosis of cancer cells and downregulate immune checkpoints in cancer and T cells, thereby eliciting strong antitumor immunity to effectively ...
Wenyao Zhen+7 more
wiley +1 more source
Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. [PDF]
Jeremy Farrar+4 more
openalex +1 more source
Machine‐Learning‐Aided Advanced Electrochemical Biosensors
Electrochemical biosensors are highly sensitive, portable, and versatile. Advanced nanomaterials enhance their performance, while machine learning (ML) improves data analysis, minimizes interference, and optimizes sensor design. Despite progress in both fields, their combined potential in diagnostics remains underexplored.
Andrei Bocan+9 more
wiley +1 more source
The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. [PDF]
Michelle M. Le Beau+6 more
openalex +1 more source
This study develops a multifunctional CRISPR‐dCas9‐based OMV platform termed OMV‐C9I12, which facilitates the coexpression of CXCL9 and IL‐12 within tumor cells. This platform enhances T cell recruitment and activation, synergizes with anti‐PD‐1/PD‐L1 immunotherapy, and amplifies antitumor T cell immunity.
Hongjin Wang+22 more
wiley +1 more source
Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. [PDF]
William L. Farrar+2 more
openalex +1 more source
Using multivariate analysis, a novel emulgel adjuvant is developed by combining key nanoemulsion formulation variables–hydrogel trapping, small globule size, and mannide monooleate surfactant–achieving 10× greater immunogenicity than MF59 in mice after a single shot.
Ahmed O. Shalash+9 more
wiley +1 more source